Health Technology Assessment Consumer Consultative Committee March 2019 meeting communiqué

20 May 2019 - A communiqué from the March 2019 meeting of the HTA Consumer Consultative Committee has been published. ...

Read more →

FDA issues draft guidance to industry on submitting real-world evidence in new drug and biologic applications

8 May 2019 - Today, the U.S. FDA published the draft guidance, Submitting Documents Using Real-World Data and Real-World Evidence ...

Read more →

Agenda for the July 2019 PBAC meeting

1 May 2019 - The agenda for the July 2019 PBAC meeting is now available. ...

Read more →

Proposal to decline inactive applications

29 April 2019 - To help make its decision-making process clearer, PHARMAC is seeking feedback on a proposal to make ...

Read more →

Additional embargo period following revised CDEC recommendations

17 April 2019 - Effective immediately, CADTH has revised its procedures for the CADTH Common Drug Review to permit an ...

Read more →

Drug makers reveal list prices online after pressure from Trump

18 April 2019 - Administration wants companies to put prices in their TV ads. ...

Read more →

PD-L(1) checkpoint inhibitor stakeholder meeting outcome statement

12 April 2019 - The outcome statement for the PD-(L)1 checkpoint inhibitor stakeholder meeting held on 8 February 2019 , ...

Read more →

Institute for Clinical and Economic Review posts draft scoping document for the assessment of treatments for rheumatoid arthritis

11 April 2019 - Document open to public comment until 1 May 2019. ...

Read more →

Institute for Clinical and Economic Review releases draft evidence report on treatments for peanut allergy

9 April 2019 - Public comment period now open until 8 May 2019; requests to make oral comment during public ...

Read more →

1 April 2019 price disclosure confirmed prices

1 April 2019 - Confirmed 1 April 2019 prices resulting from the 2019 April cycle of price disclosure have now been ...

Read more →

Assessing data sources for medicine price studies

29 March 2019 - There is no established methodology to assess the feasibility of medicine price data sources.  ...

Read more →

Major incorrect fact in the Annual Review of PHARMAC

28 March 2019 - Today the Health Select Committee released their 2017/2018 Annual Review of PHARMAC. Sadly, and disappointingly, it ...

Read more →

Highlights from CHMP 25-28 March 2019 meeting

29 March 2019 - EMA’s human medicines committee (CHMP) adopted recommendations for one new initial marketing authorisation and three extensions ...

Read more →

Drug Utilisation Sub-Committee outcome statement

29 March 2019 - The outcome statement from the February 2019 Drug Utilisation Sub-Committee meeting is now available. ...

Read more →

Eli Lilly sheds light on confidential drug pricing, discloses charges for popular diabetes medicine Humalog

25 March 2019 - Eli Lilly says the “net price” for insulin fell to $135 a patient a month in 2018 ...

Read more →